2023
DOI: 10.1080/09546634.2023.2220445
|View full text |Cite
|
Sign up to set email alerts
|

Engineering extracellular vesicles with macrophage membrane fusion for ameliorating imiquimod-induced psoriatic skin inflammation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…Accordingly, studies on the circular RNA profile associated with psoriasis identified hsa_circ_0004287 as a candidate for selectively inhibiting macrophage M1 polarization and suppressing imiquimod-induced inflammation in mice [103]. Moreover, engineered EVs produced by fusing the vesicles from annexin A1-overexpressing T lymphocytes with the plasma membranes of M2 macrophages were shown to target macrophages to selectively promote their M2 polarization, which resulted in the alleviation of psoriatic skin inflammation in imiquimod-administered mice [104].…”
Section: Therapeutic Balancing Of the Macrophage Phenotypementioning
confidence: 99%
“…Accordingly, studies on the circular RNA profile associated with psoriasis identified hsa_circ_0004287 as a candidate for selectively inhibiting macrophage M1 polarization and suppressing imiquimod-induced inflammation in mice [103]. Moreover, engineered EVs produced by fusing the vesicles from annexin A1-overexpressing T lymphocytes with the plasma membranes of M2 macrophages were shown to target macrophages to selectively promote their M2 polarization, which resulted in the alleviation of psoriatic skin inflammation in imiquimod-administered mice [104].…”
Section: Therapeutic Balancing Of the Macrophage Phenotypementioning
confidence: 99%